Sarepta Therapeutics, Inc. (SRPT)
16.76
-0.69
(-3.95%)
USD |
NASDAQ |
Feb 27, 16:00
16.70
-0.06
(-0.36%)
After-Hours: 20:00
Sarepta Therapeutics Research and Development Expense (TTM) : 1.516B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 12.71B |
| Pfizer Inc. | 10.25B |
| REGENXBIO, Inc. | 203.30M |
| Keros Therapeutics, Inc. | 157.36M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |